Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 10:46 PM
Study NCT ID:
NCT04676867
Status:
COMPLETED
Last Update Posted:
2022-12-07
First Post:
2020-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
Sponsor:
DalCor Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAL-401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None